Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTO-201 in otitis externa
NCT02511561Phase 2Completed
- Sponsor
- Otonomy, Inc.
- Start
- Jul 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ciprofloxacin in otitis externa (OE) (3 arms), sponsored by Otonomy, Inc. Primary endpoints: Otoscopic Examination: Tympanic Membrane up to 1 month, Otoscopic Examination: Middle Ear up to 1 month and 2 more. Started Jul 2015; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
otitis externa (OE)
Beyond the preview
Go deeper on NCT02511561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511561.